Document Classification

Section Type: METHODS

Text: Parameters to identify eligible patients are as follows : ESTRO : > 50 years, invasive ductal carcinoma/other favorable histology (IDC), T1-2 (3 cm), N0, any hormone receptor status, M0 ; ASTRO : 60 years, IDC, T1, N0, positive estrogen hormone receptor status, M0 ; TARGIT E '' elderly '', risk adapted radiotherapy with IORT followed by external beam radiotherapy in case of risk factors in final histopathology, phase II : 70 years, IDC, T1, N0, any hormone receptor status, M0 ; TARGIT C '' consolidation '', risk adapted radiotherapy, phase IV : 50 years, IDC, T1, N0, positive hormone receptor status, M0 ; TARGIT BQR '' boost quality registry '' : every age, every histology, T1-2 (max.